120 related articles for article (PubMed ID: 21276424)
1. Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat.
Kawai H; Deguchi S; Deguchi K; Yamashita T; Ohta Y; Omote Y; Kurata T; Ikeda Y; Matsuura T; Abe K
Brain Res; 2011 Mar; 1382():308-14. PubMed ID: 21276424
[TBL] [Abstract][Full Text] [Related]
2. Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat.
Kawai H; Deguchi S; Deguchi K; Yamashita T; Ohta Y; Shang J; Tian F; Zhang X; Liu N; Liu W; Ikeda Y; Matsuura T; Abe K
Brain Res; 2011 Jan; 1368():317-23. PubMed ID: 20971084
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine and atorvastatin exert protective and additive effects via antiapoptotic and antiautophagic mechanisms after transient middle cerebral artery occlusion in Zucker metabolic syndrome rats.
Zhang X; Deguchi S; Deguchi K; Ohta Y; Yamashita T; Shang J; Tian F; Liu N; Liu W; Ikeda Y; Matsuura T; Abe K
J Neurosci Res; 2011 Aug; 89(8):1228-34. PubMed ID: 21538457
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
5. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.
Lukic-Panin V; Kamiya T; Zhang H; Hayashi T; Tsuchiya A; Sehara Y; Deguchi K; Yamashita T; Abe K
Brain Res; 2007 Oct; 1176():143-50. PubMed ID: 17904110
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
7. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
Ivanovic B; Tadic M
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
[TBL] [Abstract][Full Text] [Related]
8. Synergistic protection against vascular inflammation with a calcium channel blocker and a statin.
Hirata Y; Sata M
Hypertens Res; 2011 Apr; 34(4):441-2. PubMed ID: 21270818
[No Abstract] [Full Text] [Related]
9. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression.
Wang L; Zhang X; Liu L; Yang R; Cui L; Li M
Neurosci Lett; 2010 Mar; 471(3):152-6. PubMed ID: 20100543
[TBL] [Abstract][Full Text] [Related]
10. Combination of amlodipine and atorvastatin synergistically reduces leukocyte recruitment to mechanically injured mouse femoral artery.
Hagita S; Osaka M; Shimokado K; Yoshida M
Hypertens Res; 2011 Apr; 34(4):450-5. PubMed ID: 21270816
[TBL] [Abstract][Full Text] [Related]
11. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
12. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
Iwamoto K; Yoshii Y; Ikeda K
Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
[TBL] [Abstract][Full Text] [Related]
14. Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?
Doyon M; Hale TM; Huot-Marchand JE; Wu R; de Champlain J; DeBlois D
Vascul Pharmacol; 2011; 54(1-2):5-12. PubMed ID: 20951229
[TBL] [Abstract][Full Text] [Related]
15. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Souza-Costa DC; Figueiredo-Lopes L; Alves-Filho JC; Semprini MC; Gerlach RF; Cunha FQ; Tanus-Santos JE
Crit Care Med; 2007 Jan; 35(1):239-45. PubMed ID: 17133179
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice.
Mogi M; Iwai M; Chen R; Iwanami J; Ide A; Tsukuda K; Yoshii T; Horiuchi M
Am J Hypertens; 2006 Nov; 19(11):1144-9. PubMed ID: 17070425
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin and amlodipine: the successful duet that led to Caduet.
Cardiovasc J Afr; 2009; 20(1):87-8. PubMed ID: 19287825
[No Abstract] [Full Text] [Related]
20. Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage.
Cui JJ; Wang D; Gao F; Li YR
Cell Biochem Biophys; 2012 Jan; 62(1):87-90. PubMed ID: 22006254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
